Stay updated on GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The record describes a Phase 1 trial of GD2-SADA:177Lu-DOTA for GD2-expressing solid tumors, including its treatment design, eligibility criteria, study locations, and outcome measures. The study is listed as terminated and no longer recruiting, and results have been posted.
    Difference
    61%
    Check dated 2026-11-09T13:48:22.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer now displays revision v3.8.0 instead of v3.7.2. The study page still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T15:45:22.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH terminology transition, stating that agencies are using “Super Intelligence” in place of “Artificial Intelligence” and linking to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T14:29:34.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The error page’s footer revision label changed from v3.7.1 to v3.7.2; the study record still displays a 403 Forbidden message.
    Difference
    0.2%
    Check dated 2026-10-19T14:12:41.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T14:52:37.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The study record has been replaced by a 403 Forbidden message and a Home link, leaving the trial details unavailable.
    Difference
    0.5%
    Check dated 2026-10-05T18:13:11.000Z thumbnail image

Stay in the know with updates to GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial page.